Related Experiment Video
Updated: May 18, 2026
07:51
Administration of Δ9-Tetrahydrocannabinol (THC) in Adolescent and Adult Mice
Published on: August 1, 2025
Using dopamine research to generate rational cannabinoid drug policy
G C Loewinger1, E B Oleson, J F Cheer
1Department of Anatomy and Neurobiology, University of Maryland School of Medicine, Baltimore, MD, USA.
Drug Testing and Analysis
|September 20, 2012
Summary
Synthetic cannabinoid (CB) regulations may hinder research. Direct CB receptor agonists show abuse potential, unlike indirect agonists, suggesting distinct regulatory approaches for therapeutic discovery.
Area of Science:
- Neuroscience
- Pharmacology
- Drug Policy
Background:
- Recreational synthetic cannabinoid use has increased, leading to widespread regulation.
- Federal agencies are reviewing five synthetic cannabinoids for permanent scheduling.
- Current regulations may impede research into therapeutic applications of cannabinoids.
Purpose of the Study:
- To review neuroscience research on synthetic cannabinoids and their therapeutic potential.
- To differentiate the abuse liability of direct versus indirect cannabinoid receptor agonists.
- To inform rational drug policy regarding cannabinoid regulation.
Main Methods:
- Neurochemical analysis of mesolimbic dopamine release.
- Review of existing neuroscience literature on synthetic cannabinoids.
- Assessment of rewarding/reinforcing effects as markers of abuse liability.
Main Results:
- Direct cannabinoid receptor agonists increase mesolimbic dopamine release, indicating abuse potential.
- Indirect cannabinoid receptor agonists do not increase mesolimbic dopamine release.
- Synthetic cannabinoids exhibit varying abuse liabilities based on their mechanism of action.
Conclusions:
- Direct and indirect cannabinoid receptor agonists should be regulated differently.
- Current scheduling of all cannabinoid receptor agonists as Schedule I may overlook medicinal properties.
- Revised policies are needed to balance regulation with therapeutic research for cannabinoids.
Related Concept Videos
01:24CNS Stimulants: Cocaine, Amphetamines and Cannabinoids
CNS stimulants, such as cocaine, amphetamines, and cannabinoids, have varying structures and mechanisms of action that lead to different therapeutic effects and side effects. Cocaine, with its molecular formula C17H21NO4, is a tropane alkaloid and a tertiary amino compound. It has two chemical forms: the hydrochloride salt and the "freebase." The former is in powder form, while the latter involves removing the hydrochloride salt to create a form that can be smoked. Cocaine exerts its effects by...
01:03Drug Control Governance: Regulatory Bodies and Their Impact
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with a...
01:21Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
Two synthetic agonists of THC,...
01:15Drug Abuse and Addiction: Pharmacological Phenomena
Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not necessarily...
01:25Drug Regulation
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
01:29Drugs Affecting Neurotransmitter Synthesis
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase, which converts...